LightPath Technologies Appoints Defense Industry Executive Mark Caylor to Board of Directors

Stock Information for Vistagen Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Vistagen Therapeutics Inc.

LightPath Technologies, Inc. Announces Pricing of $60 Million Public Offering of Common Stock
LightPath Technologies, Inc. Announces Proposed Public Offering of Common Stock
LightPath Technologies Reports Fiscal 2026 First Quarter Financial Results
LightPath Appoints Israel Piergiovanni as Vice President of Manufacturing to Support Near-Term Growth Initiatives
LightPath Technologies to Host First Quarter Fiscal 2026 Earnings Call on November 11 at 5:00 p.m. Eastern Time
LightPath Technologies Receives $4.8 Million Purchase Order for Advanced Infrared Camera Systems
LightPath Technologies Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results
LightPath Technologies to Host Fourth Quarter Fiscal 2025 Earnings Call on September 25 at 5:00 p.m. Eastern Time

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.